DT
PT
Subscribe To Print Edition About The Tribune Code Of Ethics Download App Advertise with us Classifieds
search-icon-img
search-icon-img
Advertisement

Researchers call for rapid worldwide inoculation of unvaccinated population2 doses best bet against Delta: Oxford

Aditi Tandon Tribune News Service New Delhi, August 19 Getting two vaccine doses remains the most effective way to ensure protection against the Delta variant of concern dominant in the UK and India today and present in 148 countries, according...
  • fb
  • twitter
  • whatsapp
  • whatsapp
Advertisement

Aditi Tandon

Tribune News Service

New Delhi, August 19

Advertisement

Getting two vaccine doses remains the most effective way to ensure protection against the Delta variant of concern dominant in the UK and India today and present in 148 countries, according to a study from the University of Oxford.

Published as a pre-print today, the study found that with Delta, Pfizer-BioNTech and Oxford-AstraZeneca vaccines still offered good protection against new infections, but effectiveness was reduced compared with Alpha. Researchers analysed 25,80,021 test results from over 3,80,000 participants.

Advertisement

People, who had been vaccinated after already being infected, had even more protection than vaccinated individuals who had not had Covid before. However, Delta infections after two vaccine doses had similar peak levels of virus to those in unvaccinated people; with the Alpha variant, peak virus levels in those infected post-vaccination were much lower.

Professor Sarah Walker of University of Oxford and Chief Investigator for the Covid-19 Infection Survey, said: “We don’t yet know how much transmission can happen from people who get Covid after being vaccinated but the fact that they can have high levels of virus suggests that people who aren’t yet vaccinated may not be as protected from the Delta variant as we hoped. This means it is essential for as many people as possible to get vaccinated — both in the UK and worldwide.”

This study from the Covid-19 Infection Survey is the largest to evaluate, and directly compare the real-world effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines against all infections, including those without symptoms, after the Delta variant has dominated.

Advertisement
Advertisement
Advertisement
Advertisement
tlbr_img1 Home tlbr_img2 Classifieds tlbr_img3 Premium tlbr_img4 Videos tlbr_img5 E-Paper